Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

January 9, PAA LUMC COVID-19 Research Update

210109_PAA_LUMC Update

Category: News and Announcements 2021By Richard Mollard January 8, 2021

Related posts

April 8, PharmAust Receives $750k R&D Tax Incentive Refund
April 8, 2021

April 7, LUMC: Monepantel Testing Indicates Anti-Covid19 Activity
April 7, 2021

March 31, Top 20 Shareholders
April 1, 2021

March 31, Monepantel Phase IIb Dog Lymphoma Trial Update
March 31, 2021

March 23, Epichem Waste to Fuel Licensing Agreement with Thermaquatica
March 23, 2021

February 28, Top 20 Shareholders
March 1, 2021

Recent Articles

April 8, PharmAust Receives $750k R&D Tax Incentive Refund
April 8, 2021
April 7, LUMC: Monepantel Testing Indicates Anti-Covid19 Activity
April 7, 2021
March 31, Top 20 Shareholders
April 1, 2021
March 31, Monepantel Phase IIb Dog Lymphoma Trial Update
March 31, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

PharmAust @PharmAust·

Aim to extend a dog’s life

Via @StirlingTimes

Reply on Twitter 1382483167441944577 Retweet on Twitter 13824831674419445774 Like on Twitter 138248316744194457711 Twitter 1382483167441944577

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions